Premenopausal osteoporosis in a patient with autoimmune polyglandular syndrome: A case report

Abstract

Osteoporosis is a skeletal disease characterized by low bone mass associated with decreased bone strength and increased risk of fractures. Low bone mass in premenopausal women is less common than in postmenopausal women, and bone loss in premenopausal women is usually due to secondary causes such as estrogen deficiency, glucocorticoid exposure, malabsorption, thyroid disorders, and hyperparathyroidism. In women with premenopausal osteoporosis, treatment should be planned according to the underlying secondary causes. In this case report, the importance of investigating the secondary causes leading to premenopausal osteoporosis and its treatment are discussed.

Keywords

• Autoimmune polyglandular syndrome
• diagnosis
• etiology
• , premenopausal osteoporosis
• treatment

References

1. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis.J Bone Miner Res. 1994;9(8):1137.
2. Baxter-Jones AD, Faulkner RA, Forwood MR, Mirwald RL, Bailey DA. Bone mineral accrual from 8 to 30 years of age: an estimation of peak bone mass. J Bone Miner Res. 2011;26(8):1729.
3. Lauder TD, Dixit S, Pezzin LE, Williams MV, Campbell CS, Davis GD. The relation between stress fractures and bone mineral density: evidence from active-duty Army women. Arch Phys Med Rehabil. 2000;81(1):73.
4. Jamal SA, Ridout R, Chase C, Fielding L, Rubin LA, Hawker GA. Bone mineral density testing and osteoporosis education improve lifestyle behaviors in premenopausal women: a prospective study. J Bone Miner Res. 1999;14(12):2143.
5. Liu SL, Lebrun CM. Effect of oral contraceptives and hormone replacement therapy on bone mineral density in premenopausal and perimenopausal women: a systematic review. Br J Sports Med. 2006;40(1):11.
6. McNicholl DM, Heaney LG. The safety of bisphosphonate use in pre-menopausal women on corticosteroids. Curr Drug Saf. 2010;5(2):182.